>NEWS
NEWS2019-04-16T20:08:19+00:00

SWIFT NEWS

Swift Biosciences Announces New Industry-Leading Indexed Adapters for Sequencing Larger Numbers of Samples in a Single Run

Revolutionary technology will accelerate utility of gene mapping, biomarker discovery, tumor profiling, and liquid biopsy analysis. Swift Biosciences, a leading provider of innovative library prep solutions for genomic sequencing, today announced the launch of Accel-NGS® 2S Indexed Adapters, a new portfolio of indices that significantly improves multiplexed next-generation

August 3rd, 2017|

Swift Biosciences Launches Next Phase of Company Growth and Expansion

Company completes Series D funding and adds two new directors to board. Swift Biosciences, a leading provider of innovative library prep solutions for genomic sequencing, today announced the completion of a Series D funding raise of $12.2 million. The company also announced the addition of two new directors to its board, positioning the company for accelerated growth. The Series D round was led by Arboretum Ventures

June 29th, 2017|

Swift Biosciences Launches New Assay for Faster, More Efficient Routine Screening of the CFTR Gene

Accel-Amplicon™ CFTR Panel presented at the 2017 American College of Medical Genetics Annual Meeting – Swift Biosciences today announced the commercial release of its Accel-Amplicon CFTR Panel. This panel will offer research laboratories a more comprehensive, next-generation sequencing (NGS)-based approach to interrogate the coding region and select introns within the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)

March 22nd, 2017|